On May 14-15 Saint Petersburg will yet again host Semashko Russian Pharmaceutical Forum, a major event covering key aspects of the Russian pharmaceutical regulation. As a long-standing tradition, Lidings takes part in the Forum and supports the event as a partner. This year, Lidings supports the online broadcast of this large-scale event.
Regulating and controlling authorities, business’ representatives and legal counsels focused on advising companies from the pharmaceuticals sector will once again gather together to discuss current regulation of the Life Sciences industry including analysis of recent reforms and consideration of governmental initiatives aimed at stimulating the segment development.
Representing the firm's expertise at the forum will Andrey Zelenin, Managing Partner, Head of the Life Sciences industry practice of Lidings.
Andrey will speak in a special session "Intellectual Property in Pharma - Realities, Trends, Prospects", highlighting the most relevant recent IP disputes in pharma.
***
Lidings is a leading legal advisor in Russia, acting as an expert in the statutory regulation of the Life Sciences industry. The firm’s clients are recognized leaders of the pharmaceutical market, such as Abbott, Alfasigma, Astellas, Geropharm, Glenmark, Izvarino Pharma, Ipsen, Merck, Santen, Sun Pharma, Takeda, Veropharm and many others. The firm frequently initiates and supports major international conferences devoted to issues most essential for the pharmaceutical industry in Russia and abroad. Lidings’ experts act as speakers and moderators in discussions on legal support of pharmaceutical companies doing business in the Russian Federation.
Semashko Russian Pharmaceutical Forum is one of the largest international industry events taking place in Russia. The initiative traditionally attracts manufacturers, distributors and retail chains, as well as leading experts and CEOs of the largest pharmaceutical enterprises who attend the event to discuss topics essential for the industry.
To download the Forum’s program and find out more about the speakers, please refer to the official website.